İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2023

Density functional modeling, and molecular docking with SARS-CoV-2 spike protein (Wuhan) and omicron S protein (variant) studies of new heterocyclic compounds including a pyrazoline nucleus

Dergi

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

ISSN 0739-1102

ISSN kaydı başka bir dergiye işaret ediyor; ad YÖKSİS kaydından.

YÖKSİS OpenAlex SJR Q2 JCR Q2 Atıf 25 Üst %10 Yüzdelik 93.9% FWCI 3.46
Yıl
2023
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • YÖKSİS dergi adı JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
  • Katalog eşleşmesi (ISSN) Journal of Biomolecular Structure and Dynamics
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex · İngilizce

Nowadays, different vaccines and antiviral drugs have been developed and their effectiveness has been proven against SARS-CoV-2. Pyrazoline derivatives are biologically active molecules and exhibit broad-spectrum biological activity properties. In this scope, four new molecules (4a–d) including a pyrazoline core were synthesized in order to predict their antiviral properties theoretically. Compounds 4a–d were purified by the crystallization method. The structures of 4a–d were completely characterized by NMR, IR, and elemental analysis. The molecular structures of the compounds in the ground state have been optimized using density functional theory with the B3LYP/6-31++G(d,p) level. The quantum chemical parameters were predicted by density functional theory calculations. Moreover, the molecular docking studies of 4a–d with SARS-CoV-2 Spike protein (Wuhan) and omicron S protein (variant) were presented to investigate and predict potential interactions. The binding sites, binding types and energies, bond distances of the non-covalent interactions and calculated inhibition constants (calc. Ki) as a consequence of molecular docking for 4a–d were presented in this study. Furthermore, the stability of the protein-4a complex obtained from the docking was investigated through molecular dynamics simulation.Communicated by Ramaswamy H. Sarma

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

25 atıf

OpenAlex cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 37 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. Cytotoxic activities of the pyrimidine-based acetamide and isophthalimide derivatives: an in vitro and in silico studies 2023 Atıf 35 · OpenAlex
  2. Cytotoxic activities of the pyrimidine-based acetamide and isophthalimide derivatives: An in vitro and in silico studies 2023 Atıf 35 · OpenAlex
  3. In vitro bioactivities and in silico enzyme interactions of abietatrien-3β-ol by bio-guided isolation from Nepeta italica subsp. italica 2025 Atıf 16 · OpenAlex
  4. In vitro bioactivities and in silico enzyme interactions of abietatrien-3β-ol by bio-guided isolation from Nepeta italica subsp. italica 2025 Atıf 16 · OpenAlex
  5. In vitro bioactivities and in silico enzyme interactions of abietatrien-3 β-ol by bio-guided isolation from Nepeta italica subsp. italica 2024 Atıf 16 · OpenAlex
  6. Novel Pyrrole Derivatives as Multi-Target Agents for the Treatment of Alzheimer’s Disease: Microwave-Assisted Synthesis, In Silico Studies and Biological Evaluation 2024 Atıf 15 · OpenAlex
  7. Synthesis, biological application, and computational study of a thymol-based molecule 2024 Atıf 14 · OpenAlex
  8. Synthesis, biological application, and computational study of a thymol-based molecule 2024 Atıf 14 · OpenAlex
  9. Novel Sulfonylamido Benzoxazole Derivatives: Synthesis, Characterisation, Molecular Docking, DFT, and Antimicrobial Activity Investigations 2025 Atıf 11 · OpenAlex
  10. Novel sulfonylamido benzoxazole derivatives: synthesis, characterisation, molecular docking, DFT, and antimicrobial activity investigations 2025 Atıf 11 · OpenAlex

Yazarlar

  1. Soner Akman
  2. SENEM AKKOÇ
  3. CELAL TUĞRUL ZEYREK ANKARA ÜNİVERSİTESİ
  4. MUHAMMED TILAHUN MUHAMMED
  5. İLHAN ÖZER İLHAN